What Are the Different Types of Knee Injections? Pain Management – MedicineNet

What are knee injections? Knee injection is performed to treat the pain arising from various diseases of the knee joint.

Knee injection is a procedure in which medications are injected into the knee joint to treat the pain due to various causes.

There are different types of knee injections. The most common type of intra-articular knee injection is corticosteroids. Other agents used are hyaluronic acid, infliximab, Botox (botulinum neurotoxin), and platelet-rich plasma (PRP).

Knee pain and stiffness can be debilitating and difficult to treat. Knee conditions may negatively affect the quality of life and emotional wellbeing.

Weight management, exercise, physiotherapy, medications, knee injections, and surgery are some of the approaches used to treat knee pain.

Knee pain can result from ligament or tendon injury, fracture, cartilage loss in osteoarthritis, and inflammatory conditions such as inflammatory arthritis orseptic arthritis. Knee pain can also be due to joint malalignment or dysfunction and referred pain from other areas.

Diseases of the knee can be diagnosed based on

Knee injection is performed to treat the pain arising from various diseases of the knee joint. The type of medication injected and the frequency depends on the condition being treated. Based on the diagnosis and extent of the disease, the doctor would recommend a treatment plan.

Indications for the various agents used for knee injections are as mentioned below.

Steroid injections help to relieve pain and inflammation in individuals with:

Infliximab suppresses inflammation and can be used to treat the following:

Hyaluronic acid (HA) is naturally present in the joints, eyes, and skin. HA levels decrease with age, leading to joint friction and arthritis. HA knee injections lubricate the joint, decrease friction, decrease impact, delay joint aging, reduce pain, and stiffness. HA is used in the treatment of the following:

Knee injection is a relatively quick procedure and may be performed under local anesthesia to avoid pain. A needle of appropriate size and length connected to a syringe is introduced into the joint and the medication is injected. Radiological guidance may sometimes be used to aid injection.

After the procedure, the patient would need to rest for a few minutes, and then they can resume normal activities. Patients may experience pain, swelling, and bruising, which resolve in a few days. Ice packs and pain killers can help reduce pain and bruising.

The time taken for the knee injections to work depends on the medication injected. Different medications have different durations of onset and longevity.

Complications are rare and are typically resolved. Some common complications are:

Medically Reviewed on 7/10/2020

References

Medscape Medical Reference

Read the original post:
What Are the Different Types of Knee Injections? Pain Management - MedicineNet

Coin shortage impacting Lincoln banks and businesses – Lincoln Journal Star

Shortages of goods have been common during the coronavirus pandemic, but a new supply chain problem is hitting American pockets more directly.

Banks and businesses are struggling to replace their coins due to a shortage at the Federal Reserve, altering its operations and leading to inconveniences for customers.

In an email to customers, Pinnacle Bank said they have a limited amount of coins they are receiving from the Federal Reserve. The shortage has been caused by business shutdowns, lessened production at the US Mint and a lack of change being deposited at banks.

Pinnacle Bank said they are monitoring the situation as it develops, but in the meantime they encourage customers to deposit change to help replace the bank's supply.

The effects of the shortage are trickling down to businesses as well, and some are unable to accept anything besides electronic payments and exact change. Kroger, a grocery store chain based in Cincinnati, is encouraging customers to round their total up to the nearest dollar for charity. Walmart is encouraging customers to pay electronically and is no longer distributing change from its self checkout kiosks.

Marty Jarvis, director of marketing for B&R stores, which operates Russ's Market and Super Saver in Lincoln, said the impact on their operations has been limited, but they are monitoring the situation as the shortage continues.

Originally posted here:
Coin shortage impacting Lincoln banks and businesses - Lincoln Journal Star

Oxygen Therapy Market 2020-2027 | Need for High-Speed Transport to Boost Growth | Technavio – 3rd Watch News

The report covers the forecast and analysis of the Oxygen Therapy market on a global and regional level. The study provides historical data from 2015 to 2018 along with a forecast from 2019 to 2027 based on revenue (USD Million). The study includes drivers and restraints of the Oxygen Therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Oxygen Therapy market on a global level.

In order to give the users of this report a comprehensive view of the Oxygen Therapy market, we have included a competitive landscape and an analysis of Porters Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein all the segments are bench marked based on their market size, growth rate, and general attractiveness.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10172736

The report provides company market share analysis to give a broader overview of the key players in the market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new service & product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the market on a global and regional basis.

The study provides a decisive view of the Oxygen Therapy market by segmenting the market based on oxygen source equipment, oxygen delivery devices, end-users, applications, and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2027. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Technological breakthroughs, favorable compensation policies, and massive funding of research & development activities are predicted to boost the market growth prospects over the forecast timeline. Nonetheless, huge development charges of new equipment are a key factor that is likely to hinder the expansion of the oxygen therapy industry over the forecast timeline.

Apart from this, consistently altering rules and strict policies are also anticipated to obstruct the expansion of the oxygen therapy industry during the period from 2019 to 2027. However, strategic alliances made by the major participants are anticipated to produce new growth avenues for the industry over the forecast timespan. In addition to this, new product introductions are expected to help market scape up new heights over the forecast period.

Request For Full Report:https://www.kennethresearch.com/sample-request-10172736

Based on the oxygen source equipment, the market for oxygen therapy is sectored into Oxygen Concentrators, Liquid Oxygen Systems, and Compressed Oxygen Cylinders. In terms of oxygen delivery devices, the industry is classified into Hospitals & Clinics, Retail Outlets, Banks & Financial Institutions, Government Offices, Telecom Service Center, Self Service Restaurants, and Airline Check-in Counters. On the basis of end-users, the industry is divided into Hospitals & Clinics, Rehabilitation Centers, and Home Healthcare. Application-wise, the market is divided into COPD, Pneumonia, Asthma, Respiratory Distress Syndrome (RDS), Sleep Apnea, and Cystic Fibrosis.

<<<<<>>>>> Medical Transport Services Market EEG Wearable Device Market Brazil Complementary And Alternative Medicine Market Skin And Wound Disinfection Market Cell And Gene Therapy Consumables Market United Kingdom Telemedicine Market Gene Synthesis Market

Some of the key players in the market include 3M, DeVilbiss Healthcare, Fisher & Paykel Healthcare Limited, OxyBand Technologies, Koninklijke Philips N.V., Invacare Corporation, MAQUET Holding B.V. & Co. KG., General Electric Company, Inotec AMD Limited, Teleflex Incorporated, Nidek Medical Products Inc., O2 CONCEPTS, LLC, Essex Industries, Inc., VitalAire, Inogen, ResMed, and Chart.

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email : [emailprotected]

Phone: +1 313 462 0609

Follow this link:
Oxygen Therapy Market 2020-2027 | Need for High-Speed Transport to Boost Growth | Technavio - 3rd Watch News

Advanced therapy medicinal products regulations in the EU – Regulatory Focus

This article explains some of the terminology relating to advanced therapy medicinal products (ATMPs), including gene and cell-based therapies, tissue-engineered products, and combined ATMPs. The author explains the key EU regulations and guidance documents for each therapy type, and discusses marketing authorization, accelerated regulatory pathways, and market access. He advises companies navigating this complex regulatory environment to engage with the regulatory agencies early and often during the approval process and to seek external regulatory support if in-house resources are limited. Introduction Advanced therapy medicinal products include cell therapies, gene therapies, and tissue- engineered products. These highly complex treatments differ from traditional medicines, both in how they are made and administered, and in the type of benefits they may provide. These are products for which regulations were established fairly recently and that present challenges to the regulatory agencies on how to best to regulate them within the existing regulatory framework. Terminology Gene therapies Genes therapies treat disease by replacing, inactivating, or introducing genes into the body (see Figure 1). They deliver a corrected copy of a faulty or missing gene, typically using a vector or carrier molecule. The new gene allows cells to function correctly, alleviating all, or some, disease symptoms and potentially offering a long-term cure. Gene therapy medicinal product refers to a biologic medicinal product, which has the following characteristics:

Cell-based therapies Cell-based therapies involve transplanting substantially manipulated cells or cellular material into a patient. In some cases, the genetic material in the cells may be genetically modified. Cell therapy restores or alters certain cells to deliver therapy. Cells are modified outside of the body first.

Cells may be from the patient (autologous) or from a donor (allogeneic). Autologous therapies are manufactured using cells taken from a patient, which are then re-administered to the same patient. Therefore, each batch is unique and irreplaceable. Allogenic products are those in which batches are manufactured using material from a single donor and administered to different patients. Somatic cell therapy medicinal product refers to a biological medicinal product, which has the following characteristics:

Guidance documents The European Medicines Agency (EMA) provides several guidance documents and operates a specific help desk email address (advancedtherapeis@ema.europe.com):

FIGURE 3 Marketing authorization pathways for ATMPs Reprinted with permission (Detela & Lodge)32 Market access As of May 2020, 10 ATMPs have been granted marketing authorization in Europe seven gene therapies, one cell therapy, and two tissue-engineered products targeting several diseases in different therapeutic areas. An additional five approved ATMPs were removed from the market for commercial reasons. At the time, marketing authorizations for five gene therapies were pending.38 The high number of approved, but not marketed, products can be explained at least partially by the cost of ATMPs. It is, however, important to note the fundamental differences between conventional therapies and ATMPs (see Table 2).

Outlook Navigating this complex regulatory environment means companies need to engage with the regulatory agencies early and often throughout the approval process. Many of these therapies are developed by scientific institutions and medical research groups with typically limited regulatory resources in-house, so it is advisable to seek external regulatory support. This exciting field, with hundreds of products currently tested in clinical trials,39 should yield many new therapies with enormous benefits. Something to look forward to, particularly in a time of a global pandemic crisis. Abbreviations ATMP, advanced therapy medicinal product; CAT, Committee for Advanced Therapies; CHMP, Committee for Medicinal Products for Human Use; EMA, European Medicines Agency; EU, European Union; GMP, good manufacturing practice; SMEs, small- and medium-sized enterprises. References [All references accessed 16 July 2020]

Originally posted here:
Advanced therapy medicinal products regulations in the EU - Regulatory Focus

June 2020 Global Cell Therapy Instrument Market Research Report is Projected to Witness Considerable Growth by 2027BD Bioscience, Danaher (Beckman…

Cell Therapy Instrument market research report covers and analyses several factors which affect the growth of the Cell Therapy Instrument market. The report on the Cell Therapy Instrument market also provides a detailed analysis of the major aspects of the companies such as financial aspects, research and development and the impact of the COVID-19 pandemic on these companies in the estimated forecasts period. [emailprotected] or call us on +1-312-376-8303. Download Report sample for free ckecl here: @ https://www.cognitivemarketresearch.com/machinery-%26-equipment/cell-therapy-instrument-market-report#download_report

Report Scope: Some of the key types analyzed in this report are as follows: Human Cells, Animal Cells

Some of the key applications as follow: Cell Processing, Cell Preservation Distribution & Handling, Process Monitoring & Quality Control

Following are the major key players: BD Bioscience, Danaher (Beckman Coulter Inc.), General Electric, Lonza, Merck Kgaa, Miltenyi Biotec, Sartorius AG, Stemcell Technologies Inc., Terumo Corporation, Thermo Fisher Scientific Inc. Request COVID-19 Impact Analysis for Cell Therapy Instrument by clicking on following links: @ https://www.cognitivemarketresearch.com/machinery-%26-equipment/cell-therapy-instrument-market-report#download_report

The Cell Therapy Instrument market also determines the introduction of new products and strategies which are used by several companies to reduce the impact of the pandemic of COVID-19. The research report also analyses the value chain analysis of the Cell Therapy Instrument market for the estimated forecast period. It also analyses the risk factors which are associated with the Cell Therapy Instrument market.The worldwide geological [Latin America, North America, Asia Pacific, Middle & East Africa, and Europe] analysis of the Cell Therapy Instrument market has furthermore been done cautiously in this report.

Inquiry for Buying or Customization of Report: @ https://www.cognitivemarketresearch.com/machinery-%26-equipment/cell-therapy-instrument-market-report#download_report

There are 13 Chapters to display in the Cell Therapy Instrument market: Chapter 1: Introductory overview, Specifications, Classification, and Applications of Cell Therapy Instrument market, Segment by Regions; Chapter 2: Manufacturing Cost Structure, Raw Material and Suppliers, Manufacturing Process, Industry Chain Structure; Chapter 3: Technical Data and Manufacturing Plants Analysis of Cell Therapy Instrument, Capacity and Commercial Production Rate, Manufacturing Plants Distribution, R&D Status and Technology Source, Raw Materials Sources Analysis; Chapter 4: Overall Market Analysis, Capacity Analysis (Company Segment), Sales Analysis (Company Segment), Sales Price Analysis (Company Segment); Chapter 5: Regional Analysis Chapter 6 and 7: Segment Analysis by Types and Applications Chapter 8: Company profiling of major manufacturers Chapter 9: Market Trend Analysis, Regional Market Trend, Market Trend by Product Type and Applications Chapter 10: Regional Marketing Type Analysis, International Trade Type Analysis, Supply Chain Analysis; Chapter 11, 12 and 13: Cell Therapy Instrument sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.. To check the complete Table of Content click here: @ https://www.cognitivemarketresearch.com/machinery-%26-equipment/cell-therapy-instrument-market-report#table_of_contents In addition, the report on Cell Therapy Instrument market also provides a detailed analysis of the impact of the several political, environmental, social, technological, legal and economical factors which are likely to affect the Cell Therapy Instrument market. Moreover, the change in the trading policies due to COVID-19 has also been covered in depth.The report also provides a detailed analysis of the financial information, companies which are operating and the key strategies which are used by these players to overcome the impact of the COVID-19 pandemic.

About Us: http://www.cognitivemarketresearch.com/about-us Nicolas Shaw, Sales Manager, Global Business Development, Website: http://www.cognitivemarketresearch.com Email: [emailprotected] or call us on +1-312-376-8303. Address: 20 N State Street, Chicago, Illinois, 60602, United States.

**********Download the Entire Report************************************************* https://www.cognitivemarketresearch.com/machinery-%26-equipment/cell-therapy-instrument-market-report

Read the rest here:
June 2020 Global Cell Therapy Instrument Market Research Report is Projected to Witness Considerable Growth by 2027BD Bioscience, Danaher (Beckman...

The Oncology Institute Extends Its Reach to Serve an Additional 180,000 Patients Through New Contracts and Acquisitions – Yahoo Finance

The Oncology Institute of Hope and Innovation (TOI), the largest community oncology practice on the West Coast, announced today that it has agreed to care for an additional 180,000 patients through new contracts, strategic partnerships, and practice acquisitions.

"TOIs steadfast commitment is to deliver on the promise of value-based care," shared Brad Hively, TOI CEO. "We are excited to enter into partnerships with best-in-class payors and providers, utilizing the skills of our vast network of physicians and years of experience to solve the most pressing challenges around cancer care today."

TOI recently entered into three new value-based contracts extending its reach to Los Angeles, Las Vegas, and southern Californias high desert and mountain communities.

In May, TOI acquired the practice of Dr. Manuel Zevallos, a longstanding and well-respected oncologist in Lynwood, CA. "Joining TOI was a natural fit for my practice," shared Dr. Zevallos. "We share the same evidence-based, patient-first approach." Dr. Zevallos is now practicing from TOIs Lynwood clinic, where he will continuing caring for his patients.

About The Oncology Institute of Hope and Innovation

Founded in 2007, The Oncology Institute of Hope and Innovation (TOI) is the largest community oncology practice on the west coast, and the nations leading value-based oncology services platform. TOI employs 75 physicians and mid-levels in 40 clinic locations, with over 500 total employees helping to deliver cutting edge, evidence-based cancer care to a population of over 1 million patients. TOI brings comprehensive, integrated cancer care into community settings, including Clinical Trials, Palliative Care programs, Stem Cell Transplants, Transfusions, and other care delivery models more traditionally associated with tertiary care settings. For more information visit http://www.theoncologyinstitute.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200716005221/en/

Contacts

Julie Korinke Senior Manager, Marketing 562.735.3226 x.88806 juliekorinke@theoncologyinstitute.com

Read the rest here:
The Oncology Institute Extends Its Reach to Serve an Additional 180,000 Patients Through New Contracts and Acquisitions - Yahoo Finance

Impact of COVID-19 on Osteonecrosis Treatment Market Emerging Growth And Forecast to 2027 | Bone Therapeutics, Enzo Biochem Inc., and K-Stemcell Co…

A new business intelligence report released by CMI with title Global Osteonecrosis Treatment Market Research Report 2019-2027 is designed covering micro level of analysis by manufacturers and key business segments. The Global Osteonecrosis Treatment Market survey analysis offers energetic visions to conclude and study market size, market hopes, and competitive surroundings. The research is derived through primary and secondary statistics sources and it comprises both qualitative and quantitative detailing. Some of the key players profiled in the study are Bone Therapeutics, Enzo Biochem Inc., and K-Stemcell Co Ltd. Hospitals, clinics, universities,

Whats keeping Bone Therapeutics, Enzo Biochem Inc., and K-Stemcell Co Ltd. Hospitals, clinics, universities, Ahead in the Market? Benchmark yourself with the strategic moves and findings recently released by CMI

To learn more about this report, request a samplecopy:https://www.coherentmarketinsights.com/insight/request-sample/1490

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, and Methodology.

Market Overview of Global Osteonecrosis Treatment

If you are involved in the Global Osteonecrosis Treatment industry or aim to be, then this study will provide you inclusive point of view. Its vital you keep your market knowledge up to date segmented by Applications and major players. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization according to your requirement.

This study mainly helps understand which market segments or Region or Country they should focus in coming years to channelize their efforts and investments to maximize growth and profitability. The report presents the market competitive landscape and a consistent in depth analysis of the major vendor/key players in the market.

Furthermore, the years considered for the study are as follows:

Historical year 2014 2018

Base year 2019

Forecast period** 2019 to 2027 [** unless otherwise stated]

**Moreover, it will also include the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product services of key players.

Detailed Segmentation:

By Drug ClassNon-steroidal anti-inflammatory drugs (NSAIDS)Anti-coagulantOther drugsBy Distribution ChannelsHospitals pharmaciesRetail pharmaciesOnline pharmacies

Top Players in the Market are: Bone Therapeutics, Enzo Biochem Inc., and K-Stemcell Co Ltd. Hospitals, clinics, universities,

(*Note: Other Players can be added per Request)

Regions included:

o North America (United States, Canada, and Mexico)

o Europe (Germany, France, UK, Russia, and Italy)

o Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)

o South America (Brazil, Argentina, Colombia)

o Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

[**NOTE: Enquiry before Buying option enables you to share your queries, in advance to procure the report. Kindly fill the enquiry form, and one of our consultants would get in touch with you to discuss the queries and would address them.]

Else place an Inquire before Purchase Global Osteonecrosis Treatment Market Size, Share, Growth, and Forecast 2027 @https://www.coherentmarketinsights.com/insight/request-customization/1490

Important Features that are under offering & key highlights of the report:

Detailed overview of Osteonecrosis Treatment market

Changing market dynamics of the industry

In-depth market segmentation by Type, Application etc

Historical, current and projected market size in terms of volume and value

Recent industry trends and developments

Competitive landscape of Osteonecrosis Treatment market

Strategies of key players and product offerings

Potential and niche segments/regions exhibiting promising growth

A neutral perspective towards Osteonecrosis Treatment market performance

Market players information to sustain and enhance their footprint

Note: *The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @https://www.coherentmarketinsights.com/insight/request-pdf/1490

Major Highlights of TOC:

Chapter One: Global Osteonecrosis Treatment Market Industry Overview

1.1 Osteonecrosis Treatment Industry

1.1.1 Overview

1.1.2 Products of Major Companies

1.2 Osteonecrosis Treatment Market Segment

1.2.1 Industry Chain

1.2.2 Consumer Distribution

1.3 Price & Cost Overview

Chapter Two: Global Osteonecrosis Treatment Market Demand

2.1 Segment Overview

2.1.1 APPLICATION 1

2.1.2 APPLICATION 2

2.1.3 Other

2.2 Global Osteonecrosis Treatment Market Size by Demand

2.3 Global Osteonecrosis Treatment Market Forecast by Demand

Chapter Three: Global Osteonecrosis Treatment Market by Type

3.1 By Type

3.1.1 TYPE 1

3.1.2 TYPE 2

3.2 Osteonecrosis Treatment Market Size by Type

3.3 Osteonecrosis Treatment Market Forecast by Type

Chapter Four: Major Region of Osteonecrosis Treatment Market

4.1 Global Osteonecrosis Treatment Sales

4.2 Global Osteonecrosis Treatment Revenue & market share

Chapter Five: Major Companies List

Chapter Six: Conclusion

Key questions answered

o Who are the Leading key players and what are their Key Business plans in the Global Osteonecrosis Treatment market?

o What are the key concerns of the five forces analysis of the Global Osteonecrosis Treatment market?

o What are different prospects and threats faced by the dealers in the Global Osteonecrosis Treatment market?

o What are the strengths and weaknesses of the key vendors?

Need a discount?

Request discount for this report @https://www.coherentmarketinsights.com/insight/request-discount/1490

Note: *The discount is offered on the Standard Price of the report.an

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

About Coherent Market Insights

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact US

Mr.Shah Phone: US +1-206-701-6702/UK +44-020 8133 4027 [emailprotected]

Go here to read the rest:
Impact of COVID-19 on Osteonecrosis Treatment Market Emerging Growth And Forecast to 2027 | Bone Therapeutics, Enzo Biochem Inc., and K-Stemcell Co...

Patient-Reported Outcomes After Platelet-Rich Plasma, Bone Marrow Aspirate, and Adipose-Derived Mesenchymal Stem Cell Injections for Symptomatic Knee…

Objective:The objective of this study was to compare platelet-rich plasma (PRP), bone marrow aspirate concentrate (BMAC), and adipose-derived mesenchymal stem cell (MSC) injections in the treatment of osteoarthritis (OA) of the knee using functional scores.

Methods:A total of 89 patients with painful knee OA were included in this study. Patients were assigned to one of the 3 treatments according to severity of OA as indicated by symptoms and radiography to PRP (stage I), BMAC (stage II), or adipose-derived MSC (stage III). Clinical assessment was performed using the Knee Society Score, which combines the Knee Score, based on the clinical parameters, and the Functional Score, and IKDC score. Surveys were completed at preoperative and at 90, 180, and 265 days postoperative. The follow-up responses were compared with baseline and between treatment groups.

Results:Treatment with PRP, BMAC, and adipose-derived MSC included 29 (32.6%), 27 (30.3%), and 33 (37.1%) patients, respectively. For the total group, median age was 61 years (range: 22-84 years). Score values were comparable among treatment groups at baseline. Statistically significant improvement was observed in the 3 groups according to the 3 scores at all time points during follow-up compared with baseline. No difference was found among treatment type.

Conclusions:Our findings support previous reports and encourage further research on the use of these cost-effective treatments for OA of the knee.

Keywords:Platelet-rich plasma; adipose-derived mesenchymal stem cell; bone marrow aspirate concentrate; knee; osteoarthritis.

See the original post:
Patient-Reported Outcomes After Platelet-Rich Plasma, Bone Marrow Aspirate, and Adipose-Derived Mesenchymal Stem Cell Injections for Symptomatic Knee...

Post COVID 19 Pandemic Global Canine Stem Cell Therapy Market Research Report 2020 Top Players Include, VETSTEM BIOPHARMA, Cell Therapy Sciences,…

Global Canine Stem Cell Therapy Market analysis 2015-2027, is a research report that has been compiled by studying and understanding all the factors that impact the market in a positive as well as negative manner. Some of the prime factors taken into consideration are: various rudiments driving the market, future opportunities, restraints, regional analysis, various types & applications, Covid-19 impact analysis and key market players of the Canine Stem Cell Therapy market. nicolas.shaw@cognitivemarketresearch.com or call us on +1-312-376-8303.

Download Report from: https://cognitivemarketresearch.com/medical-devicesconsumables/canine-stem-cell-therapy-market-report

Global Canine Stem Cell Therapy Market: Product analysis: Allogeneic Stem Cells, Autologous Stem cells

Global Canine Stem Cell Therapy Market: Application analysis: Veterinary Hospitals, Veterinary Clinics, Veterinary Research Institutes

Major Market Players with an in-depth analysis: VETSTEM BIOPHARMA, Cell Therapy Sciences, Regeneus, Aratana Therapeutics, Medivet Biologics, Okyanos, Vetbiologics, VetMatrix, Magellan Stem Cells, ANIMAL CELL THERAPIES, Stemcellvet

The research is presented in such a way that it consists of all the graphical representations, pie charts and various other diagrammatic representations of all the factors that are used for the research. Canine Stem Cell Therapy market research report also provides information on how the industry is anticipated to provide a highly competitive analysis globally, revenues generated by the industry and increased competitiveness and expansions among various market players/companies.

Get A Free Sample of Canine Stem Cell Therapy Market Report: https://cognitivemarketresearch.com/medical-devicesconsumables/canine-stem-cell-therapy-market-report#download_report

The Canine Stem Cell Therapy industry is projected in assembling information regarding dynamic approximations and also listings of a profitable progression rate annually in the expected duration according to a recent & latest study. The latest Coronavirus pandemic impact along with graphical presentations and recovery analysis is included in the Canine Stem Cell Therapy research report. The research report also consists of all the latest innovations, technologies and systems implemented in the Canine Stem Cell Therapy industries.

Various factors with all the necessary limitations, expenditure/cost figures, consumer behaviour, supply chain, government policies and all the information related to the market have been included in the Canine Stem Cell Therapy Market report. The research report also provides light on various companies & their competitors, market size & share, revenue, forecast analysis and all the information regarding the Canine Stem Cell Therapy Market.

Checkout Inquiry for Buying or Customization of Report: https://cognitivemarketresearch.com/medical-devicesconsumables/canine-stem-cell-therapy-market-report#download_report.

Canine Stem Cell Therapy Market research report provides an in-depth analysis of the entire market scenario starting from the basics which is the market introduction till the industry functioning and its position in the market as well as all the projects and latest introductions & implementations of various products. The research study has been assembled by understanding and combining various analysis of regions globally & companies and all necessary graphs and tables that bring the theory into an exact representation through numerical values and standard tables.

The global estimations of the market value, market information/definition, classifications of all the types & applications, overall threats & dips that can be assumed and many other factors which consist the overall market scenario and its happening globally along with the forthcoming years are compiled in the Canine Stem Cell Therapy market research report. Hence this report can serve as a handbook/model for the enterprises/players interested in the Canine Stem Cell Therapy Market as it consists all the information regarding the Canine Stem Cell Therapy market.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here> Download Sample Report of Canine Stem Cell Therapy Market Report 2020 (Coronavirus Impact Analysis on Canine Stem Cell Therapy Market)

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19. (*If you have any special requirements, please let us know and we will offer you the report as you want.)

About Us: Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients. We focus on making sure that based on our reports, our clients are enabled to make most vital business decisions in easiest and yet effective way. Hence, we are committed to delivering them outcomes from market intelligence studies which are based on relevant and fact-based research across the global market. Contact Us: +1-312-376-8303 Email: nicolas.shaw@cognitivemarketresearch.com Web: https://www.cognitivemarketresearch.com/

**********Download the Entire Report************************************************* https://cognitivemarketresearch.com/medical-devicesconsumables/canine-stem-cell-therapy-market-report

View post:
Post COVID 19 Pandemic Global Canine Stem Cell Therapy Market Research Report 2020 Top Players Include, VETSTEM BIOPHARMA, Cell Therapy Sciences,...

Can banking your stem cells prevent aging? | Well+Good

Ugggghh, getting old sucks!Its something you hear all the time, right? From a 31-year-old, suddenly unable to have two glasses of wine without waking up hungover the next day. A 43-year-old with a bum knee. A 65-year-old who cant remember where she put her keys. And on. And on. And on.

As conventional wisdomhas it, the effects of aging are non-negotiable. Plus, people are living longer than ever, which potentially means more years spent in less-than-optimal condition. But proponents of a new technologystem-cell bankingclaim getting older doesnt have to come with the irreversible downward health spiral weve all been conditioned to expect. Their claim: Storing and eventually re-injecting your own adult stem cells may help your body heal the first signs of age-related disease down the line, keeping you feeling vital longer.

Sounds intriguingbut is it legit?

Heres the deal: Stem cellsare unspecialized cellsthat have the potential to multiply and grow into many different types of cells throughout the body, from bone to muscle to neuron and beyond. By extracting and freezing these repair cells from your own bodybanking them, essentiallythe idea is that when your health starts to decline, you can have them reinserted into your body right at the site of the problem. If you start suffering from arthritis, for example, your stored stem cells would be inserted into your joints so healthy cells will multiply and take over, theoretically eliminating your pain.

One such stem-cell preservation company isForever Labs, which is currently working with physicians in Los Angeles, New York, Miami, Boston, Washington, DC, and more.Forever Labs was born out of our own mid-life crises, says strategic growth expert Steve Clausnitzer, who co-founded the biz with friend and longtime stem-cell researcher Mark Katakowski, PhD.Three years ago, I was turning 40, and I said to Steve, Im convinced that I want to have my young cells later in life, Katakowski says. And he said, You know what? Id like to have that too.

Related Stories

{{ truncate(post.title, 18) }}

Those young cells they were talking about are, of course, stem cells. Doctors are already using these to help the body heal, taking healthy stem cells from a strong part of the body and immediately transplanting them to whatever area new cells are needed. Orthopedic surgeons and sports medicine doctors use bone marrow-derived stem cells to treat injuries, including joint issues and musculoskeletal problems. Theyre regularly used for skin graftsand forcancer patients, replacing blood-formingcellsdestroyed by chemo or radiation.

Armin Tehrany, MD, founder of Manhattan Orthopedic Care(who is unaffiliated with Forever Labs), sees stem-cell therapy as an effective form of treatmentat least in his field of medicinealthough he admits scientists arent exactly sure how or why it works. There are theories that what [stem cells] do is attach to the bodys actual tissue and potentially change the tissue turning those cells on so they become what theyre supposed to be, as opposed to being degenerated part of the tissue, he says.

Banking yourself basically creates a pool of young biology that doesnt experience the wear and tear of life. Steve Clausnitzer, Forever Labs cofounder

Yet, as Katakowski will tell you, one of the sad truths about stem cells is that they lose function as they age. For 17 years, Id been working with bone-marrow stem cells developing treatment for stroke and other neural injuries and diseases, learning firsthand the therapeutic value of the cells, but also that the number of cells and their efficacy is less with age, he explains.

Thats where stem cell banking comes in. Extracting them from your bone marrow or fat stores and cryogenically freezing them while theyre still young and strong is an entirely new concept. (In fact, Forever Labs is the first company thats set on using stem cells to extend human healthspans.) But that may be about to change. Theres been an explosion of clinical application of this knowledgea couple hundred clinical studies at last count,Katakowski says.

Why bank your own stem cells, as opposed to, say, getting them from a younger donor? The short answer is that if you want to replace tissue, you need your own cells, Katakowski says. There is some evidence that you can get some acute benefit using someone elses, but its a short kind of benefit because cells dont stick around. Your body finds them and weeds them out. (Its similar to the way bodies sometimes reject a transplanted organthat means theres no bank-one-for-the-whole-family type of deal.)

Katakowski believes the best time to bank stem cells is between the ages of 20 and 40. That said, he still advises older people to do it, toohis mother banked hers at 70. Dr. Tehrany says its more important to consider your health than actual age when considering any type of stem-cell therapy. Someone can be 75, butphysiologically and genetically be 55, he says. [Conversely,] if someones overall health is declining, its safe to say their stem cell functionality is declining too.

So lets say you buy into this whole freezing-your-stem-cells thing. When, exactly, would you ask for them back? According to Katakowski and Clausnitzer, the time to use them is when you start experiencing undesirable health impacts brought on by aging. This can be caused by something sudden, like having a stroke, or something you notice gradually, like a slow decline in memory. At that point, a doctor would inject your stored stem cells back into the affected body part. (Or partsbecause, lets be honest, aging is a full-body kind of deal.)In theory, the stem cells would then help the not-so-healthy tissue regenerate and become more vital.

Emphasis on the theory part. Since the technology is still so new, its actual success rate is still very much TBD. While Forever Labs has undertaken many encouraging studies with mice, the companys human studiesmore than 700 of themare still underway, and it will take years to see the long-term effects. Dr. Tehrany affirms that this is cutting-edge stuff, and the scientific backup just isnt there yet. But that doesnt mean hes ruling out the stem-cell banking concept. Based on how successful stem cells are as a treatment, I do think its important to respect and value the potential of them as a preventative, he says.

Theres also the lingering thought that maybe youll get lucky and age without any problems at all. Then, wouldnt it be a huge waste of money to pay for decades of stem-cell freezing? (At $2,500 for the procedure and $300 a year for storage, it isnt cheap.) After all, theres tons of emerging research that indicates a healthy diet and regular exercisecan go a long way in preventing age-related declineand those are basically free.(Ah, the boring, yet sound advice thats been preached for decades.)

Clausnitzer personally believes its not wise to play the odds. Theres a lot of evidence that as you get into middle age, all this damage accrues in your cells and a lot of that is irreversible, such as DNA mutations, Clausnitzer says. Banking yourself basically creates a pool of young biology that doesnt experience the wear and tear of life. So what you bank is kind of like the seeds that you can use to grow many, many of your own young stem cells to treat yourself.

Ultimately, no so-called illness-proofing option comes with any guarantees, making the choice a totally personal one. But it does raise the question: If youre 90 years old, but your cells are only 40, how old are you really?

Speaking of longevity, this is the type of exercise thatll add years to your life. Having these personality traits helps, too.

Read more:
Can banking your stem cells prevent aging? | Well+Good